(Q59389220)
Statements
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis (English)
F Patti
M P Amato
L Caniatti
E Di Monte
P Ferrazza
B Goretti
P Gallo
V Brescia Morra
S Lo Fermo
M R Tola
M Trojano
COGIMUS Study Group
7 December 2009